Publication of Asklepios CSRD Report 2024
|
EQS-News: Asklepios Kliniken
/ Key word(s): ESG/Sustainability
Asklepios Group: Publication of Asklepios CSRD Report 2024 Hamburg, 30 April 2025. Asklepios Kliniken GmbH & Co. KGaA has published its audited CSRD Report for financial year 2024. Asklepios Kliniken GmbH & Co. KGaA today published its audited CSRD Report as an integral part of the Annual Report for financial year 2024. In addition to all relevant key figures, it also documents the achievements of Asklepios in the areas of environmental, social and governance. For the first time, the sustainability section of the Report was prepared voluntarily in accordance with the European Sustainability Reporting Standards (ESRS). Asklepios has identified the following topics as material and reports on them fully in accordance with the relevant standards: Environment (E1 Climate change; E5 Resource use and circular economy), Social (S1 Own workforce; S4 Consumers and end-users/patients) and governance (G1 Conduct of business). For each topic, the Asklepios Report discloses the impacts, risks and opportunities identified and shows how Asklepios has integrated environment, social and governance matters in its strategy, central control processes and management systems and/or will implement such measures going forward. In a structured process coordinated and agreed in parallel, Asklepios prepared and implemented the CSRD Report jointly with the sub-groups RHÖN-KLINIKUM AG and MEDICLIN AG. The goal of this uniform approach is to consolidate the CSRD Report for financial year 2025. About Asklepios Asklepios Kliniken is one of the leading operators of private hospitals and healthcare facilities in Germany. The hospital group has an established track record for delivering high-quality medical care to its patients with a clear commitment to medical quality, innovation and social responsibility. This is what has underpinned Asklepios’ dynamic development ever since its founding more than 35 years ago. Currently, the Group has some 160 healthcare facilities throughout Germany. These include acute hospitals of all care levels, university hospitals, specialised clinics, psychiatric and forensic facilities, rehabilitation hospitals, nursing homes and medical care centres. During financial year 2024, a total of 3,643,901 patients were treated at Asklepios’ healthcare facilities. Inpatient cases totalled 777,889. Outpatient cases stood at 2,866,012. The Company employs more than 70,000 persons. You can find the 2024 Annual Report including the CSRD Sustainability Statement at Asklepios - Publikationen. IR contact: PR contact: Visit Asklepios on the Internet, Facebook or YouTube: Sign up for the Asklepios Newsletter: Nursing blog: “Wir sind Pflege” (We are Nursing)
30.04.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
2127276 30.04.2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.